Optimizing Data Quality and Compliance Through Integrated Validation Strategies for Clinical Systems
Keywords:
integrated data validation, clinical systems, quality management, risk-based monitoringAbstract
This article presents a comprehensive analysis of integrated data validation strategies in clinical systems, aimed at enhancing their quality and regulatory compliance. The study employs an interdisciplinary approach that combines risk-based quality management, data model standardization, and multi-level assessment procedures, including DQA and SSDQA, with a focus on their reproducibility and scalability. Particular attention is given to a comparative analysis of the operational efficiency of direct data entry and automated transfer from medical information systems, with a detailed evaluation of their impact on data preparation speed, metric reproducibility, reduction of transcription errors, and monitoring workload. Key factors determining validation effectiveness have been identified, including trial portfolio size, maturity of digital infrastructure, personnel readiness, and regional implementation specifics. Quantitative indicators of RBQM adoption and related tools, as well as data fitness-for-use metrics obtained from multicenter projects with varying levels of quality control maturity, are presented. The optimal validation architecture is defined as incorporating unified standards, continuous control during the execution stage, and adaptation of tools to local conditions to minimize risks. The article will be useful for clinical research professionals, data quality management system developers, regulatory experts, healthcare IT architects, and researchers in the field of digital transformation of medical technologies.
References
Afroz, M. A., Schwarber, G., & Bhuiyan, M. A. N. (2021). Risk-based centralized data monitoring of clinical trials during the time of COVID-19 pandemic. Contemporary Clinical Trials, 104, 106368. https://doi.org/10.1016/j.cct.2021.106368
Bhagat, R., Bojarski, L., Chevalier, S., et al. (2021). Quality tolerance limits: Framework for successful implementation in clinical development. Therapeutic Innovation & Regulatory Science, 55, 251–261. https://doi.org/10.1007/s43441-020-00209-0
Blacketer, C., Defalco, F. J., Ryan, P. B., & Rijnbeek, P. R. (2021). Increasing trust in real-world evidence through evaluation of observational data quality. Journal of the American Medical Informatics Association, 28(10), 2251–2257. https://doi.org/10.1093/jamia/ocab132
Cramer, A. E., King, L. S., Buckley, M. T., Casteleyn, P., Ennis, C., Hamidi, M., Rodrigues, G. M. C., Snyder, D. C., Vattikola, A., & Eisenstein, E. L. (2024). Defining methods to improve eSource site start-up practices. Contemporary Clinical Trials Communications, 42, 101391. https://doi.org/10.1016/j.conctc.2024.101391
de Viron, S., Trotta, L., Steijn, W., Young, S., & Buyse, M. (2024). Does central statistical monitoring improve data quality? An analysis of 1,111 sites in 159 clinical trials. Therapeutic Innovation & Regulatory Science, 58(3), 483–494. https://doi.org/10.1007/s43441-024-00613-w
Dirks, A., Florez, M., Torche, F., Young, S., Slizgi, B., & Getz, K. (2024). Comprehensive assessment of risk-based quality management adoption in clinical trials. Therapeutic Innovation & Regulatory Science, 58(3), 520–527. https://doi.org/10.1007/s43441-024-00618-5
Hallinan, C. M., Ward, R., Hart, G. K., Sullivan, C., Pratt, N., Ng, A. P., Capurro, D., Van Der Vegt, A., Liaw, S. T., Daly, O., Luxan, B. G., Bunker, D., & Boyle, D. (2024). Seamless EMR data access: Integrated governance, digital health and the OMOP-CDM. BMJ Health & Care Informatics, 31(1), e100953. https://doi.org/10.1136/bmjhci-2023-100953
Kilaru, R., Amodio, S., Li, Y., et al. (2024). An overview of current statistical methods for implementing quality tolerance limits. Therapeutic Innovation & Regulatory Science, 58, 273–284. https://doi.org/10.1007/s43441-023-00598-y
Lewis, A. E., Weiskopf, N., Abrams, Z. B., Foraker, R., Lai, A. M., Payne, P. R. O., & Gupta, A. (2023). Electronic health record data quality assessment and tools: A systematic review. Journal of the American Medical Informatics Association, 30(10), 1730–1740. https://doi.org/10.1093/jamia/ocad120
Mueller, C., Herrmann, P., Cichos, S., Remes, B., Junker, E., Hastenteufel, T., & Mundhenke, M. (2023). Automated electronic health record to electronic data capture transfer in clinical studies in the German health care system: Feasibility study and gap analysis. Journal of Medical Internet Research, 25, e47958. https://doi.org/10.2196/47958
Razzaghi, H., Goodwin Davies, A., Boss, S., Bunnell, H. T., Chen, Y., Chrischilles, E. A., Dickinson, K., Hanauer, D., Huang, Y., Ilunga, K. T. S., Katsoufis, C., Lehmann, H., Lemas, D. J., … Bailey, L. C. (2024). Systematic data quality assessment of electronic health record data to evaluate study-specific fitness: Report from the PRESERVE research study. PLOS Digital Health, 3(6), e0000527. https://doi.org/10.1371/journal.pdig.0000527
Yaegashi, H., Hayashi, Y., Takeda, M., et al. (2024). Efficiency of eSource direct data capture in investigator-initiated clinical trials in oncology. Therapeutic Innovation & Regulatory Science, 58, 1031–1041. https://doi.org/10.1007/s43441-024-00671-0
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ratna Jyothi Kommaraju
This work is licensed under a Creative Commons Attribution 4.0 International License.
